Sarepta surges after FDA panel backs Duchenne gene therapy

By Aditya Samal (Reuters) -Shares of Sarepta Therapeutics jumped 25% on Monday as a backing by the U.S. health regulator’s advisers increased the certainty of an accelerated approval for the company’s gene therapy for a muscle-wasting genetic disorder. The stock was set for its biggest percentage jump in over three years, while the drugmaker’s market…

Read More

Explainer-How Wall Street is preparing for possible US debt default

By Davide Barbuscia and Pete Schroeder NEW YORK/WASHINGTON (Reuters) – As talks over raising the U.S. government’s $31.4 trillion debt ceiling intensify, Wall Street banks and asset managers have begun preparing for fallout from a potential default. The financial industry has prepared for such a crisis before, most recently in September 2021. But this time,…

Read More

Brazil’s Americanas looking for buyer for stake in Grupo Uni.co

SAO PAULO (Reuters) – Brazilian retailer Americanas SA, which filed for bankruptcy earlier this year after an accounting scandal, said on Monday it has started the market sounding process to prospect parties interested in buying its stake in Grupo Uni.co. Americanas, which has the billionaire trio that founded 3G Capital as reference shareholders, said in…

Read More